Correlation Between Affimed NV and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Cue Biopharma, you can compare the effects of market volatilities on Affimed NV and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Cue Biopharma.
Diversification Opportunities for Affimed NV and Cue Biopharma
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Affimed and Cue is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Affimed NV i.e., Affimed NV and Cue Biopharma go up and down completely randomly.
Pair Corralation between Affimed NV and Cue Biopharma
Given the investment horizon of 90 days Affimed NV is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Affimed NV is 1.35 times less risky than Cue Biopharma. The stock trades about -0.04 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 208.00 in Cue Biopharma on August 27, 2024 and sell it today you would lose (106.00) from holding Cue Biopharma or give up 50.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Affimed NV vs. Cue Biopharma
Performance |
| Timeline |
| Affimed NV |
| Cue Biopharma |
Affimed NV and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Affimed NV and Cue Biopharma
The main advantage of trading using opposite Affimed NV and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Affimed NV vs. Eliem Therapeutics | Affimed NV vs. HCW Biologics | Affimed NV vs. Scpharmaceuticals | Affimed NV vs. Milestone Pharmaceuticals |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |